Invention Grant
- Patent Title: Peptides derived from human PCSK9 catalytic domain and uses thereof for promoting LDL-R activity
-
Application No.: US15547277Application Date: 2016-01-29
-
Publication No.: US10557129B2Publication Date: 2020-02-11
- Inventor: Ajoy Basak
- Applicant: Pronasci Inc.
- Applicant Address: CA Montreal
- Assignee: Pronasci inc.
- Current Assignee: Pronasci inc.
- Current Assignee Address: CA Montreal
- Agency: Benoit & Cote, Inc.
- Agent Mathieu Miron
- International Application: PCT/CA2016/050080 WO 20160129
- International Announcement: WO2016/119067 WO 20160804
- Main IPC: C07K7/08
- IPC: C07K7/08 ; C12N9/64 ; A61K38/48 ; A61K45/06
Abstract:
The present invention provides compositions comprising an isolated or purified therapeutically effective hPCSK9 polypeptide derived from the hPCSK9 catalytic domain, and their use in methods of treating hypercholesterolemia.
Public/Granted literature
- US20180023071A1 PEPTIDES DERIVED FROM HUMAN PCSK9 CATALYTIC DOMAIN AND USES THEREOF FOR PROMOTING LDL-R ACTIVITY Public/Granted day:2018-01-25
Information query
